Stockscreener 앱 받기
2.21
1.34%
-0.03
시간 외 거래:
2.23
0.02
+0.90%
전일 마감가:
$2.24
열려 있는:
$2.2
하루 거래량:
12,888
Relative Volume:
0.21
시가총액:
$2.91M
수익:
$574.20K
순이익/손실:
$-11.52M
주가수익비율:
-0.0482
EPS:
-45.8332
순현금흐름:
$-6.92M
1주 성능:
+27.75%
1개월 성능:
+8.33%
6개월 성능:
+203.57%
1년 성능:
+447.03%
1일 변동 폭
$2.20
$2.24
1주일 범위
$1.75
$2.24
52주 변동 폭
$0.31
$5.89
애틀론 메디컬 Stock (AEMD) Company Profile
명칭
Aethlon Medical Inc
전화
619-941-0360
주소
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
2.21 | 2.95M | 574.20K | -11.52M | -6.92M | -45.83 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
애틀론 메디컬 Stock (AEMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 재개 | H.C. Wainwright | Neutral |
애틀론 메디컬 주식(AEMD)의 최신 뉴스
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2026 earnings call transcript - MSN
OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, CEO and CFO of Aethlon Medical, and M. Marin, Senior Analyst at Zacks SCR - Yahoo Finance
Aethlon Medical announces full exercise of pre-funded warrants By Investing.com - Investing.com India
Aethlon Medical announces full exercise of pre-funded warrants - Investing.com
Aethlon Medical, Inc. Announces All Pre-Funded Warrants Exercised; 1,569,110 Shares Outstanding as of March 16, 2026 - Minichart
Aethlon Medical Completes Pre-Funded Warrant Exercises, Simplifying Equity - TipRanks
All Aethlon Medical (AEMD) pre-funded warrants exercised, 1,569,110 shares out - Stock Titan
Aethlon Medical hires Maxim Group to explore strategic options - Investing.com Nigeria
AEMD Technical Analysis & Stock Price Forecast - Intellectia AI
Aethlon Medical at Life Sciences Forum: Hemopurifier’s Oncology Focus By Investing.com - Investing.com Canada
Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: AEMD) Gains on News - Investorideas.com
Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: AEMD) Engages Maxim Group LLC to Evaluate Strategic Opportunities - Investorideas.com
Aethlon Medical (AEMD) Explores Strategic Opportunities with Max - GuruFocus
Aethlon Medical hires Maxim Group to explore strategic options By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Cancer and infection treatment developer Aethlon explores deals with Maxim - Stock Titan
Aethlon Medical Q1 2026 Earnings Preview - MSN
Winners Losers: Is Aethlon Medical Inc showing insider buyingIPO Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Investment Review: Whats the profit margin of Aethlon Medical IncPortfolio Value Report & Verified Short-Term Plans - baoquankhu1.vn
Aethlon Medical to Present at Life Sciences Investor Forum - Intellectia AI
Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th - GlobeNewswire
Energy Moves: Can Aethlon Medical Inc continue delivering strong returnsInsider Buying & Safe Capital Growth Trade Ideas - baoquankhu1.vn
AEMD SEC FilingsAethlon Medical 10-K, 10-Q, 8-K Forms - Stock Titan
Totaligent Executes Binding LOI for Joint Venture and Acquisition of GloMed Solutions - Benzinga
Aethlon Medical to Present at Emerging Growth Conference - Intellectia AI
Ask Aethlon Medical’s CEO and CFO live at Emerging Growth Conference - Stock Titan
Zacks Research Weighs in on Aethlon Medical FY2026 Earnings - Defense World
Can Aethlon Medical Inc. deliver consistent dividendsJuly 2025 Chart Watch & Fast Gaining Stock Reports - mfd.ru
FY2026 EPS Estimate for Aethlon Medical Decreased by Analyst - Defense World
How Aethlon Medical Inc. stock reacts to global recession fearsJuly 2025 Sentiment & Daily Stock Trend Watchlist - mfd.ru
Armistice Capital (NASDAQ: AEMD) reports 9.99% ownership of Aethlon Medical - Stock Titan
Aug Swings: Why Aethlon Medical Inc. (EJU) stock is a must watch tickerShare Buyback & Weekly Stock Performance Updates - mfd.ru
Aethlon Medical Q2 2026 Earnings Preview - MSN
Aethlon Medical Inc (AEMD) Q3 2026 Earnings Call Highlights: Progress in Oncology Trials and ... By GuruFocus - Investing.com Canada
Aethlon Medical Inc (AEMD) Q3 2026 Earnings Call Highlights: Pro - GuruFocus
Can Aethlon Medical Inc. stock continue upward trendQuarterly Risk Review & Verified Momentum Stock Alerts - mfd.ru
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2026 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Aethlon Medical Q3 2026 sees operational strides amid financial challenges - Investing.com Australia
Will Aethlon Medical Inc. benefit from geopolitical trendsJuly 2025 Final Week & AI Powered Buy and Sell Recommendations - mfd.ru
Aethlon Medical, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Aethlon Medical Q3 2026 Earnings Call Transcript - MarketBeat
Why did Aethlon Medical stock tumble over 12% today? - MSN
AEMD: Australian oncology trial advances and cost controls drive 27% lower nine-month expenses - TradingView
AETHLON MEDICAL INC SEC 10-Q Report - TradingView
Aethlon Medical Posts Q3 Results, Highlights Hemopurifier Progress - TipRanks
Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update - Yahoo Finance
What’s the profit margin of Aethlon Medical Inc.Insider Selling & Short-Term High Return Ideas - mfd.ru
How interest rate cuts could boost Aethlon Medical Inc. stockTrade Entry Summary & Community Consensus Picks - mfd.ru
Aethlon Medical to Announce Q3 Earnings on February 11 - Intellectia AI
Analysis Recap: What are analysts price targets for CleanSpark IncJuly 2025 Movers & Consistent Return Strategy Ideas - baoquankhu1.vn
Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: AEMD) to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026 - Investorideas.com
애틀론 메디컬 (AEMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):